Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
DAXOR CORP
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
DAXOR CORP
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
DAXOR CORP
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
$
DXR
DAXOR CORP
CIK:
0000027367
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
REVENUES:
Operating revenues - equipment sales and related services
$ 1,125,249
$ 1,242,264
Operating revenues - cryobanking and related services
321,096
336,993
Total Revenues
1,446,345
1,579,257
Costs of sales-equipment sales and related services
616,063
691,786
Costs of sales-cryobanking and related services
36,448
35,864
Total Costs of Sales
652,511
727,650
Gross Profit
793,834
851,607
OPERATING EXPENSES:
Research and development-equipment sales and related services
2,508,657
2,826,068
Research and development-cryobanking and related services
197,295
215,572
Total Research and Development Expenses
2,705,952
3,041,640
Selling, general, and administrative- equipment sales and related services
3,219,204
2,750,626
Selling, general and administrative- cryobanking and related services
655,092
718,452
Total Selling, General and Administrative Expenses
3,874,296
3,469,078
Total Operating Expenses
6,580,248
6,510,718
Loss from Operations
(5,786,414)
(5,659,111)
Dividend income-investment portfolio
2,237,734
2,226,198
Realized gains on sale of securities, net
33,189
13,509,318
Mark to market of short positions
(8,501,859)
(1,526,064)
Other revenues
12,374
12,166
Interest expense, net of interest income of $6,425 and $1,944
(168,923)
(61,676)
Administrative expenses relating to portfolio investments
(153,816)
(150,675)
Total Other (expense) income, net
(6,541,301)
14,009,267
(Loss) Income before income taxes
(12,327,715)
8,350,156
(Benefit ) provision for income taxes
(5,142,076)
3,381,892
Net (Loss) Income
(7,185,639)
4,968,264
Weighted average number of shares outstanding – basic and diluted
$ 4,219,654
$ 4,237,216
Net (loss) income per common equivalent share –basic and diluted (in Dollars per share)
$ (1.70)
$ 1.17
Dividends paid per common share (in Dollars per share)
$ 0.25
$ 1.00
v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income
$ (7,185,639)
$ 4,968,264
Depreciation & amortization
290,791
296,554
Deferred income taxes
(3,190,269)
(1,017,042)
Provision for bad debts
5,000
32,981
Gain on sale of fixed assets
(52,533)
Loss on disposal of fixed assets
19,835
Stock dividend income received on investments
(7,028)
Stock based compensation associated with employee stock option plans
9,731
Gains on sale of investments, net
(33,189)
(13,509,318)
Marked to market adjustments on options and shorts
8,501,859
1,526,064
(Increase ) decrease in accounts receivable
(45,864)
28,814
(Increase) in prepaid expenses & other current assets
(78,779)
(26,129)
(Increase) in Income Tax Refund Receivable
(2,013,031)
Decrease in inventory
62,100
90,773
Increase (decrease) in accounts payable and accrued liabilities
88,626
(97,089)
(Decrease) increase in income taxes payable
(2,899,707)
2,043,725
(Decrease) increase in deferred income
(13,249)
5,018
Net cash used in operating activities
(6,508,648)
(5,690,083)
Purchase of property and equipment
(123,150)
(324,710)
Proceeds from sale of fixed assets
65,000
Increase in receivable from broker
(812,134)
(11,699,512)
Increase in securities borrowed
730,784
11,634,757
Purchases of put and call options
(8,961,293)
(419,080)
Sale of put and call options
14,318,728
18,623,868
Purchase of investments
(25,722,529)
(28,856,997)
Sales of investments
9,181,156
20,378,599
Net cash (used in) provided by investing activities
(11,388,438)
9,401,925
Proceeds from margin loan payable
44,633,031
41,462,399
Repayment of margin loan payable
(25,404,421)
(40,877,703)
Dividends paid
(1,054,450)
(4,229,520)
Repayment of mortgage
(44,853)
(43,431)
Purchase of treasury stock
(230,337)
(242,934)
Net cash provided by(used in) financing activities
17,898,970
(3,931,189)
Net increase (decrease) in cash and cash equivalents
1,884
(219,347)
Cash and cash equivalents at beginning of year
57,741
277,088
Cash and cash equivalents at end of year
59,625
57,741
Interest
175,348
63,916
Income taxes
$ 3,002,828
$ 2,424,813
v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2011
Dec. 31, 2010
CURRENT ASSETS
Cash and cash equivalents
$ 59,625
$ 57,741
Receivable from broker
23,078,775
32,382,439
Available-for-sale securities, at fair value
55,804,364
53,876,071
Accounts receivable, net of reserve of $130,402 in 2011 and $125,402 in 2010
219,684
178,820
Inventory
301,534
363,634
Income tax refund receivable
2,013,031
Prepaid expenses and other current assets
209,339
130,560
Total Current Assets
81,686,352
86,989,265
Property and equipment, net
4,001,351
4,168,992
Other assets
37,158
37,158
Total Assets
85,724,861
91,195,415
CURRENT LIABILITIES
Accounts payable and accrued liabilities
525,168
436,542
Loans payable
13,751,008
4,638,197
Income taxes payable
87,093
2,986,800
Mortgage payable, current portion
58,054
46,798
Puts and calls, at fair value
7,103,448
4,330,069
Securities borrowed, at fair value
23,136,820
22,406,036
Deferred revenue
38,671
51,920
Deferred income taxes
4,564,054
9,003,946
Total Current Liabilities
49,264,316
43,900,308
LONG TERM LIABILITIES
Mortgage payable, less current portion
243,954
300,063
Total Liabilities
49,508,270
44,200,371
STOCKHOLDERS’ EQUITY
Outstanding – 4,202,351 and 4,226,137 shares, respectively
53,165
53,165
Additional paid in capital
10,684,752
10,675,228
Accumulated other comprehensive income
12,572,514
14,890,272
Retained earnings
24,740,252
32,980,341
Less: cost of common stock held in treasury, at cost, 1,114,179 shares in 2011 and 1,090,413 in 2010
(11,834,092)
(11,603,962)
Total Stockholders’ Equity
36,216,591
46,995,044
Total Liabilities and Stockholders’ Equity
$ 85,724,861
$ 91,195,415